The department of nuclear medicine at the university hospital Klinikum rechts der Isar of the Munich Technical University today started clinical use testing with a world’s first in medical technology, thereby opening up new perspectives for the diagnosis of diseases such as cancer or dementia.
The combination of a magnetic resonance tomograph (MR) and a positron emission tomograph (PET) in one device allows doctors – for the first time – to simultaneously see the position of internal organs, how these are working, as well as their metabolism, all in a single image. This may help doctors to make a more accurate diagnoses by not only seeing where a tumor is in the body, but also its type and its activity. Moreover it may display how the body reacts to medication administered to the patient. The device, called the Biograph mMR*, has been developed by Siemens Healthcare and is a pioneering achievement in medical imaging.
The Biograph mMR combines two technologies that normally would not be able to work next to each other: Magnetic resonance imaging uses a strong magnetic field and electromagnetic waves, while positron emission tomography uses low-dose radioactively charged radiopharmaceuticals, with which the patient is injected before the examination. These radiopharmaceuticals react with the body tissue and the resulting radiation is measured and finally converted into an image. According to physics applied in these imaging techniques, those two technologies should conflict with each other and make simultaneous imaging impossible. But the Biograph mMR is designed to overcome this physical hurdle. Thanks to funding of the Deutsche Forschungsgemeinschaft (DFG) the first systems will be installed in Germany.
In his remarks at the celebratory commissioning of the device, Bavarian Minister President Horst Seehofer said, “Bavaria’s high-tech architects like Siemens, combined with the top-notch science that we have here in both university hospitals in Munich, result in the kind of strong partnership that contribute to Bavaria’s strength and prosperity and that is the envy of many around the world. Before the upcoming holiday season, Bavaria will enact a new future-focused program called “Bavaria on the Move.” Under this program, we will continue to make significant investments in research and technology throughout all parts of the Bavarian state. This is, and will remain, Bavaria’s sovereign path toward prosperity and employment.”
MRI and PET are already well-established imaging techniques in medicine, and have been used for a long time to answer important clinical questions. Now, the combination of both technologies in one system is expected to change the diagnosis of many diseases, including many types of cancer as well as dementia. ”Together with our partner Siemens we are entering a new dimension in diagnostic imaging today“, said Prof. Dr. Markus Schwaiger, Director of the department for nuclear medicine at the university hospital. „We’ve initiated clinical use testing of Biograph mMR in an effort to diagnose diseases at a very early stage; to see the progression of disease and to use that information to develop a therapy plan precisely focused on the respective patient. Furthermore, we plan to use the system for cancer follow-up in the long run, by reducing radiation exposure by the use of the system.“In addition, the combination of the two systems will significantly cut the time needed for an examination compared to when two separate systems are used. The same works for the space – where room was needed for two large machines before, now only one combined machine is required. That gives hospitals more space for patients. “We can master the challenges of our healthcare systems only if we detect diseases as early as possible and treat them appropriately, while keeping an eye on costs,” explained Dr. Hermann Requardt, CEO of the Siemens Healthcare Sector. “Our Biograph mMR is a tool for doctors, enabling them to more quickly and accurately collect information on the type, stage, and progress of cancers, for example. The system may also be suitable for monitoring the progress and effectiveness of therapies. The Biograph mMR at the hospital Rechts der Isar clinic is a milestone in image-based diagnostics.”
Tanja Schmidhofer | Uni München
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine